{"id":340150,"date":"2025-08-20T10:36:54","date_gmt":"2025-08-20T10:36:54","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-teva-pharmaceutical-industries-limited\/"},"modified":"2025-08-20T10:36:54","modified_gmt":"2025-08-20T10:36:54","slug":"how-to-buy-teva-pharmaceutical-industries-limited","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-teva-pharmaceutical-industries-limited\/","title":{"rendered":"Teva Pharmaceutical Industries Limited (TEVA) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Teva Pharmaceutical Industries Limited (TEVA) Hisse Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334027,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-340150","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Teva Pharmaceutical Industries Limited (TEVA) Hisseleri Nas\u0131l Al\u0131n\u0131r - Teva Pharmaceutical Industries Limited (TEVA) Hisse Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Teva Pharmaceutical Industries Limited (TEVA) Hisseleri Nas\u0131l Al\u0131n\u0131r - Teva Pharmaceutical Industries Limited (TEVA) Hisse Yat\u0131r\u0131m\u0131"},"description":"Teva Pharmaceutical Industries Limited (TEVA) hisselerinin nas\u0131l al\u0131naca\u011f\u0131n\u0131 kapsaml\u0131 yat\u0131r\u0131m analizi, g\u00fcncel hisse performans\u0131 ve 2025-2030 fiyat tahminleri ile \u00f6\u011frenin ve bilin\u00e7li ticaret kararlar\u0131 verin.","description_source":{"label":"Description","type":"textarea","formatted_value":"Teva Pharmaceutical Industries Limited (TEVA) hisselerinin nas\u0131l al\u0131naca\u011f\u0131n\u0131 kapsaml\u0131 yat\u0131r\u0131m analizi, g\u00fcncel hisse performans\u0131 ve 2025-2030 fiyat tahminleri ile \u00f6\u011frenin ve bilin\u00e7li ticaret kararlar\u0131 verin."},"intro":"D\u00fcnyan\u0131n en b\u00fcy\u00fck jenerik ila\u00e7 \u00fcreticilerinden birine yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Teva Pharmaceutical Industries Limited, yat\u0131r\u0131mc\u0131lar\u0131n dikkatini \u00e7eken benzersiz bir istikrar ve b\u00fcy\u00fcme potansiyeli kar\u0131\u015f\u0131m\u0131 sunuyor. On ard\u0131\u015f\u0131k \u00e7eyrek b\u00fcy\u00fcme ve k\u00fcresel olarak geni\u015fleyen stratejik ortakl\u0131klarla, bu ila\u00e7 sekt\u00f6r\u00fcne yat\u0131r\u0131m i\u00e7in sizin giri\u015f noktan\u0131z olabilir.","intro_source":{"label":"Intro","type":"text","formatted_value":"D\u00fcnyan\u0131n en b\u00fcy\u00fck jenerik ila\u00e7 \u00fcreticilerinden birine yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Teva Pharmaceutical Industries Limited, yat\u0131r\u0131mc\u0131lar\u0131n dikkatini \u00e7eken benzersiz bir istikrar ve b\u00fcy\u00fcme potansiyeli kar\u0131\u015f\u0131m\u0131 sunuyor. On ard\u0131\u015f\u0131k \u00e7eyrek b\u00fcy\u00fcme ve k\u00fcresel olarak geni\u015fleyen stratejik ortakl\u0131klarla, bu ila\u00e7 sekt\u00f6r\u00fcne yat\u0131r\u0131m i\u00e7in sizin giri\u015f noktan\u0131z olabilir."},"body_html":"<h2>\ud83d\udcc8 Teva Hissesi: G\u00fcncel Fiyat ve Piyasa Konumu<\/h2> <p>20 A\u011fustos 2025 itibar\u0131yla, Teva Pharmaceutical Industries Limited (TEVA) NYSE'de <strong>18,06 $<\/strong> fiyatla i\u015flem g\u00f6r\u00fcyor. \u015eirket, Q2 2025'te 10. ard\u0131\u015f\u0131k b\u00fcy\u00fcme \u00e7eyre\u011fini ger\u00e7ekle\u015ftirerek ve \u00f6nemli yenilik\u00e7i \u00fcr\u00fcnler i\u00e7in gelir beklentisini art\u0131rarak dikkat \u00e7ekici bir dayan\u0131kl\u0131l\u0131k g\u00f6sterdi.<\/p> <p><strong>\u00d6nemli Tarih Uyar\u0131s\u0131<\/strong>: Takviminize <strong>5 Kas\u0131m 2025<\/strong> tarihini i\u015faretleyin. Bu tarihte Teva, Q3 2025 kazan\u00e7 raporunu a\u00e7\u0131klayacak. Tarihsel olarak, bu \u00e7eyreklik a\u00e7\u0131klamalar \u00f6nemli fiyat hareketlerine neden olmu\u015ftur.<\/p> <h3><strong>Kazan\u00e7 Etkisi Analizi<\/strong>:<\/h3> <ul> <li>30 Temmuz 2025: Q2 kazan\u00e7lar\u0131 a\u00e7\u0131kland\u0131 - hisse senedi gelir rakamlar\u0131na kar\u0131\u015f\u0131k tepkilerle hemen volatilite g\u00f6sterdi<\/li> <li>Nisan 2025: Q1 sonu\u00e7lar\u0131, beklenenden iyi yenilik\u00e7i ila\u00e7 sat\u0131\u015flar\u0131 sonras\u0131 %9 fiyat art\u0131\u015f\u0131 sa\u011flad\u0131<\/li> <li>\u015eubat 2025: Y\u0131ll\u0131k rapor, Medicare Part D yeniden tasar\u0131m\u0131 endi\u015feleri nedeniyle %13 d\u00fc\u015f\u00fc\u015fe yol a\u00e7t\u0131<\/li> <\/ul> <p>Model, pozitif kazan\u00e7 s\u00fcrprizlerinin genellikle s\u00fcrd\u00fcr\u00fclebilir yukar\u0131 y\u00f6nl\u00fc ivme yaratt\u0131\u011f\u0131n\u0131, aksiliklerin ise genellikle al\u0131m f\u0131rsat\u0131 sunan ge\u00e7ici d\u00fc\u015f\u00fc\u015flere neden oldu\u011funu g\u00f6steriyor.<\/p> <h3><strong>6 Ayl\u0131k Performans Yolculu\u011fu (\u015eubat-A\u011fustos 2025)<\/strong>:<\/h3> <p>Teva hisseleri etkileyici bir volatilite g\u00f6sterirken genel olarak pozitif bir trend sergiledi:<\/p> <table> <thead> <tr> <th>Ay<\/th> <th>Fiyat Aral\u0131\u011f\u0131<\/th> <th>Temel Kataliz\u00f6r<\/th> <\/tr> <\/thead> <tbody> <tr> <td>\u015eubat<\/td> <td>15,20 $-16,80 $<\/td> <td>Medicare endi\u015feleri<\/td> <\/tr> <tr> <td>Mart<\/td> <td>16,50 $-17,80 $<\/td> <td>FDA onaylar\u0131 art\u0131\u015f\u0131<\/td> <\/tr> <tr> <td>Nisan<\/td> <td>17,20 $-18,40 $<\/td> <td>Q1 kazan\u00e7lar\u0131 beklentiyi a\u015ft\u0131<\/td> <\/tr> <tr> <td>May\u0131s<\/td> <td>17,80 $-18,20 $<\/td> <td>Ortakl\u0131k duyurular\u0131<\/td> <\/tr> <tr> <td>Haziran<\/td> <td>18,00 $-18,50 $<\/td> <td>Fosun Pharma i\u015f birli\u011fi<\/td> <\/tr> <tr> <td>Temmuz<\/td> <td>17,60 $-18,30 $<\/td> <td>Q2 kazan\u00e7 a\u00e7\u0131klamas\u0131<\/td> <\/tr> <tr> <td>A\u011fustos<\/td> <td>17,80 $-18,20 $<\/td> <td>Mevcut konsolidasyon<\/td> <\/tr> <\/tbody> <\/table> <p>Hisse senedi bu d\u00f6nemde yakla\u015f\u0131k <strong>%18<\/strong> kazan\u00e7 sa\u011flad\u0131; ba\u015far\u0131l\u0131 ila\u00e7 lansmanlar\u0131 ve stratejik ortakl\u0131klar bunu destekledi.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udd2e <strong>Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/strong><\/h2> <ul> <li><strong>2025 Y\u0131l Sonu<\/strong>: 19-21 $ (g\u00fc\u00e7l\u00fc tatil sezonu sat\u0131\u015flar\u0131 + yeni \u00fcr\u00fcn lansmanlar\u0131) \u2192 <strong>AL<\/strong><\/li> <li><strong>2026<\/strong>: 22-25 $ (biyobenzer pazar geni\u015flemesi + bor\u00e7 azalt\u0131m\u0131)<\/li> <li><strong>2028<\/strong>: 28-32 $ (yenilik\u00e7i portf\u00f6y hakimiyeti + uluslararas\u0131 b\u00fcy\u00fcme)<\/li> <li><strong>2030<\/strong>: 35-40 $ (pazar liderli\u011fi peki\u015ftirme + \u00fcr\u00fcn hatt\u0131 olgunla\u015fmas\u0131)<\/li> <\/ul> <p>2027 y\u0131l\u0131na kadar 700 milyon dolar net tasarruf sa\u011flayan d\u00f6n\u00fc\u015f\u00fcm programlar\u0131, bu yukar\u0131 y\u00f6nl\u00fc ivme i\u00e7in g\u00fc\u00e7l\u00fc temel destek sunuyor.<\/p> <h2>\u26a0\ufe0f <strong>\u00d6nemli Riskler ve Pozitif Sinyaller<\/strong><\/h2> <h3><strong>Dikkate Al\u0131nmas\u0131 Gereken Riskler:<\/strong><\/h3> <ul> <li>\u0130la\u00e7 fiyatland\u0131rmas\u0131n\u0131 etkileyen d\u00fczenleyici de\u011fi\u015fiklikler<\/li> <li>Patent davalar\u0131 giderleri<\/li> <li>Jenerik rekabet bask\u0131s\u0131<\/li> <li>D\u00f6viz dalgalanmalar\u0131 (%68 uluslararas\u0131 gelir)<\/li> <li>Bor\u00e7 y\u00f6netimi<\/li> <\/ul> <h3><strong>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar:<\/strong><\/h3> <ul> <li>10 ard\u0131\u015f\u0131k b\u00fcy\u00fcme \u00e7eyre\u011fi<\/li> <li>Austedo sat\u0131\u015flar\u0131nda y\u0131ll\u0131k %40 art\u0131\u015f<\/li> <li>Asya'da Fosun Pharma ortakl\u0131\u011f\u0131<\/li> <li>\u015eimdiden 140 milyon dolar y\u0131ll\u0131k tasarruf sa\u011fland\u0131<\/li> <li>Birden fazla biyobenzer lansman planlan\u0131yor<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f <strong>Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/strong><\/h2> <ol> <li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong> - Haftal\u0131k yat\u0131r\u0131mlarla dolar maliyeti ortalamas\u0131 yap\u0131n<\/li> <li><strong>Fiyat uyar\u0131lar\u0131 kurun<\/strong> - 5 Kas\u0131m kazan\u00e7 tarihi civar\u0131n\u0131 takip edin<\/li> <li><strong>Ak\u0131ll\u0131ca \u00e7e\u015fitlendirin<\/strong> - Portf\u00f6y\u00fcn\u00fcz\u00fcn %15'inden az\u0131n\u0131 ila\u00e7 sekt\u00f6r\u00fcne ay\u0131r\u0131n<\/li> <li><strong>Esprili yakla\u015f\u0131m<\/strong>: \"TEVA ticareti yapmak ila\u00e7 almak gibidir - bazen tad\u0131 ac\u0131 olabilir ama uzun vadede portf\u00f6y sa\u011fl\u0131\u011f\u0131n\u0131z i\u00e7in iyidir!\"<\/li> <\/ol> <h2>\u2705 <strong>Teva Pharmaceutical Industries Limited (TEVA) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/strong><\/h2> <table> <thead> <tr> <th>Ad\u0131m<\/th> <th>\u0130\u015flem<\/th> <th>Neden \u00d6nemli<\/th> <\/tr> <\/thead> <tbody> <tr> <td>1<\/td> <td>Bir ticaret platformu se\u00e7in<\/td> <td>NYSE eri\u015fimi ve par\u00e7al\u0131 hisse sunan bir platform olmas\u0131na dikkat edin<\/td> <\/tr> <tr> <td>2<\/td> <td>Hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n<\/td> <td>Hisse senedi ticareti uyumlulu\u011fu i\u00e7in gereklidir<\/td> <\/tr> <tr> <td>3<\/td> <td>Fon yat\u0131r\u0131n<\/td> <td>Risk almaya haz\u0131r oldu\u011funuz bir miktarla ba\u015flay\u0131n<\/td> <\/tr> <tr> <td>4<\/td> <td>\"TEVA\" aramas\u0131 yap\u0131n<\/td> <td>Do\u011fru sonu\u00e7lar i\u00e7in sembol\u00fc kullan\u0131n<\/td> <\/tr> <tr> <td>5<\/td> <td>Sipari\u015f t\u00fcr\u00fcn\u00fc se\u00e7in<\/td> <td>Limit emirleri volatilite s\u0131ras\u0131nda fazla \u00f6deme yapman\u0131z\u0131 engeller<\/td> <\/tr> <tr> <td>6<\/td> <td>\u00dccretleri g\u00f6zden ge\u00e7irin<\/td> <td>Komisyonsuz platformlar getiriyi maksimize eder<\/td> <\/tr> <tr> <td>7<\/td> <td>Al\u0131m\u0131 ger\u00e7ekle\u015ftirin<\/td> <td>Sipari\u015f detaylar\u0131n\u0131 onaylay\u0131n ve tamamlay\u0131n<\/td> <\/tr> <tr> <td>8<\/td> <td>Takip kurun<\/td> <td>Fiyat uyar\u0131lar\u0131 performans\u0131 izlemenize yard\u0131mc\u0131 olur<\/td> <\/tr> <tr> <td>9<\/td> <td>DRIP'i d\u00fc\u015f\u00fcn\u00fcn<\/td> <td>Otomatik yeniden yat\u0131r\u0131m kazan\u00e7lar\u0131 katlar<\/td> <\/tr> <tr> <td>10<\/td> <td>D\u00fczenli olarak g\u00f6zden ge\u00e7irin<\/td> <td>\u00c7eyreklik kazan\u00e7lar \u00f6nemli karar noktalar\u0131d\u0131r<\/td> <\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 <strong>Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Pocket Option'un \u00d6ne \u00c7\u0131kma Nedenleri<\/strong><\/h2> <p>Pocket Option, yeni ba\u015flayanlar i\u00e7in tasarlanm\u0131\u015f \u00f6zelliklerle borsa giri\u015fini kolayla\u015ft\u0131r\u0131r:<\/p> <ul> <li><strong>Sadece 5 $ minimum depozito<\/strong> - Stratejileri d\u00fc\u015f\u00fck riskle test edin<\/li> <li><strong>1 dakikal\u0131k KYC s\u00fcreci<\/strong> - Tek belge do\u011frulamas\u0131 ile hemen i\u015flem yapmaya ba\u015flay\u0131n<\/li> <li><strong>100'den fazla para \u00e7ekme y\u00f6ntemi<\/strong> - Karlar\u0131n\u0131za esnek eri\u015fim<\/li> <li><strong>Par\u00e7al\u0131 hisse imkan\u0131<\/strong> - Pahal\u0131 hisselerin par\u00e7alar\u0131n\u0131 sat\u0131n al\u0131n<\/li> <li><strong>Ger\u00e7ek zamanl\u0131 piyasa verisi<\/strong> - G\u00fcncel bilgilerle bilin\u00e7li kararlar verin<\/li> <\/ul> <p>Platformun kullan\u0131c\u0131 dostu aray\u00fcz\u00fc ve e\u011fitim kaynaklar\u0131, Teva Pharmaceutical Industries Limited (TEVA) hisseleri nas\u0131l al\u0131n\u0131r \u00f6\u011frenirken riski etkin y\u00f6netmek isteyenler i\u00e7in idealdir.<\/p> <h2>\ud83c\udf0d <strong>2025'te Teva: \u0130la\u00e7 Devi D\u00f6n\u00fc\u015f\u00fcm\u00fc<\/strong><\/h2> <p>Teva, k\u00fcresel jenerik ila\u00e7 pazar\u0131nda hakimiyet kurarken, daha y\u00fcksek marjl\u0131 yenilik\u00e7i ila\u00e7lara ba\u015far\u0131l\u0131 bir ge\u00e7i\u015f yap\u0131yor. Austedo (hareket bozukluklar\u0131 i\u00e7in), Ajovy (migren \u00f6nleme) ve Uzedy (\u015fizofreni tedavisi) gibi markal\u0131 portf\u00f6y\u00fc, geleneksel jenerik i\u015finin yan\u0131nda \u00f6nemli b\u00fcy\u00fcmeyi sa\u011fl\u0131yor.<\/p> <p><strong>2025 \u0130lgin\u00e7 Ger\u00e7ek<\/strong>: Teva'n\u0131n \u0130srail'deki genel merkezi, havay\u0131 do\u011fal olarak ar\u0131tan ve enerji maliyetlerini %15 azaltan 10.000'den fazla bitki i\u00e7eren bir \"ya\u015fayan duvar\"a sahip - s\u00fcrd\u00fcr\u00fclebilirli\u011fe olan ba\u011fl\u0131l\u0131klar\u0131n\u0131n ila\u00e7lar\u0131n \u00f6tesine ge\u00e7ti\u011fini kan\u0131tl\u0131yor!<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Teva Hissesi: G\u00fcncel Fiyat ve Piyasa Konumu<\/h2>\n<p>20 A\u011fustos 2025 itibar\u0131yla, Teva Pharmaceutical Industries Limited (TEVA) NYSE&#8217;de <strong>18,06 $<\/strong> fiyatla i\u015flem g\u00f6r\u00fcyor. \u015eirket, Q2 2025&#8217;te 10. ard\u0131\u015f\u0131k b\u00fcy\u00fcme \u00e7eyre\u011fini ger\u00e7ekle\u015ftirerek ve \u00f6nemli yenilik\u00e7i \u00fcr\u00fcnler i\u00e7in gelir beklentisini art\u0131rarak dikkat \u00e7ekici bir dayan\u0131kl\u0131l\u0131k g\u00f6sterdi.<\/p>\n<p><strong>\u00d6nemli Tarih Uyar\u0131s\u0131<\/strong>: Takviminize <strong>5 Kas\u0131m 2025<\/strong> tarihini i\u015faretleyin. Bu tarihte Teva, Q3 2025 kazan\u00e7 raporunu a\u00e7\u0131klayacak. Tarihsel olarak, bu \u00e7eyreklik a\u00e7\u0131klamalar \u00f6nemli fiyat hareketlerine neden olmu\u015ftur.<\/p>\n<h3><strong>Kazan\u00e7 Etkisi Analizi<\/strong>:<\/h3>\n<ul>\n<li>30 Temmuz 2025: Q2 kazan\u00e7lar\u0131 a\u00e7\u0131kland\u0131 &#8211; hisse senedi gelir rakamlar\u0131na kar\u0131\u015f\u0131k tepkilerle hemen volatilite g\u00f6sterdi<\/li>\n<li>Nisan 2025: Q1 sonu\u00e7lar\u0131, beklenenden iyi yenilik\u00e7i ila\u00e7 sat\u0131\u015flar\u0131 sonras\u0131 %9 fiyat art\u0131\u015f\u0131 sa\u011flad\u0131<\/li>\n<li>\u015eubat 2025: Y\u0131ll\u0131k rapor, Medicare Part D yeniden tasar\u0131m\u0131 endi\u015feleri nedeniyle %13 d\u00fc\u015f\u00fc\u015fe yol a\u00e7t\u0131<\/li>\n<\/ul>\n<p>Model, pozitif kazan\u00e7 s\u00fcrprizlerinin genellikle s\u00fcrd\u00fcr\u00fclebilir yukar\u0131 y\u00f6nl\u00fc ivme yaratt\u0131\u011f\u0131n\u0131, aksiliklerin ise genellikle al\u0131m f\u0131rsat\u0131 sunan ge\u00e7ici d\u00fc\u015f\u00fc\u015flere neden oldu\u011funu g\u00f6steriyor.<\/p>\n<h3><strong>6 Ayl\u0131k Performans Yolculu\u011fu (\u015eubat-A\u011fustos 2025)<\/strong>:<\/h3>\n<p>Teva hisseleri etkileyici bir volatilite g\u00f6sterirken genel olarak pozitif bir trend sergiledi:<\/p>\n<table>\n<thead>\n<tr>\n<th>Ay<\/th>\n<th>Fiyat Aral\u0131\u011f\u0131<\/th>\n<th>Temel Kataliz\u00f6r<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>\u015eubat<\/td>\n<td>15,20 $-16,80 $<\/td>\n<td>Medicare endi\u015feleri<\/td>\n<\/tr>\n<tr>\n<td>Mart<\/td>\n<td>16,50 $-17,80 $<\/td>\n<td>FDA onaylar\u0131 art\u0131\u015f\u0131<\/td>\n<\/tr>\n<tr>\n<td>Nisan<\/td>\n<td>17,20 $-18,40 $<\/td>\n<td>Q1 kazan\u00e7lar\u0131 beklentiyi a\u015ft\u0131<\/td>\n<\/tr>\n<tr>\n<td>May\u0131s<\/td>\n<td>17,80 $-18,20 $<\/td>\n<td>Ortakl\u0131k duyurular\u0131<\/td>\n<\/tr>\n<tr>\n<td>Haziran<\/td>\n<td>18,00 $-18,50 $<\/td>\n<td>Fosun Pharma i\u015f birli\u011fi<\/td>\n<\/tr>\n<tr>\n<td>Temmuz<\/td>\n<td>17,60 $-18,30 $<\/td>\n<td>Q2 kazan\u00e7 a\u00e7\u0131klamas\u0131<\/td>\n<\/tr>\n<tr>\n<td>A\u011fustos<\/td>\n<td>17,80 $-18,20 $<\/td>\n<td>Mevcut konsolidasyon<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Hisse senedi bu d\u00f6nemde yakla\u015f\u0131k <strong>%18<\/strong> kazan\u00e7 sa\u011flad\u0131; ba\u015far\u0131l\u0131 ila\u00e7 lansmanlar\u0131 ve stratejik ortakl\u0131klar bunu destekledi.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udd2e <strong>Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/strong><\/h2>\n<ul>\n<li><strong>2025 Y\u0131l Sonu<\/strong>: 19-21 $ (g\u00fc\u00e7l\u00fc tatil sezonu sat\u0131\u015flar\u0131 + yeni \u00fcr\u00fcn lansmanlar\u0131) \u2192 <strong>AL<\/strong><\/li>\n<li><strong>2026<\/strong>: 22-25 $ (biyobenzer pazar geni\u015flemesi + bor\u00e7 azalt\u0131m\u0131)<\/li>\n<li><strong>2028<\/strong>: 28-32 $ (yenilik\u00e7i portf\u00f6y hakimiyeti + uluslararas\u0131 b\u00fcy\u00fcme)<\/li>\n<li><strong>2030<\/strong>: 35-40 $ (pazar liderli\u011fi peki\u015ftirme + \u00fcr\u00fcn hatt\u0131 olgunla\u015fmas\u0131)<\/li>\n<\/ul>\n<p>2027 y\u0131l\u0131na kadar 700 milyon dolar net tasarruf sa\u011flayan d\u00f6n\u00fc\u015f\u00fcm programlar\u0131, bu yukar\u0131 y\u00f6nl\u00fc ivme i\u00e7in g\u00fc\u00e7l\u00fc temel destek sunuyor.<\/p>\n<h2>\u26a0\ufe0f <strong>\u00d6nemli Riskler ve Pozitif Sinyaller<\/strong><\/h2>\n<h3><strong>Dikkate Al\u0131nmas\u0131 Gereken Riskler:<\/strong><\/h3>\n<ul>\n<li>\u0130la\u00e7 fiyatland\u0131rmas\u0131n\u0131 etkileyen d\u00fczenleyici de\u011fi\u015fiklikler<\/li>\n<li>Patent davalar\u0131 giderleri<\/li>\n<li>Jenerik rekabet bask\u0131s\u0131<\/li>\n<li>D\u00f6viz dalgalanmalar\u0131 (%68 uluslararas\u0131 gelir)<\/li>\n<li>Bor\u00e7 y\u00f6netimi<\/li>\n<\/ul>\n<h3><strong>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar:<\/strong><\/h3>\n<ul>\n<li>10 ard\u0131\u015f\u0131k b\u00fcy\u00fcme \u00e7eyre\u011fi<\/li>\n<li>Austedo sat\u0131\u015flar\u0131nda y\u0131ll\u0131k %40 art\u0131\u015f<\/li>\n<li>Asya&#8217;da Fosun Pharma ortakl\u0131\u011f\u0131<\/li>\n<li>\u015eimdiden 140 milyon dolar y\u0131ll\u0131k tasarruf sa\u011fland\u0131<\/li>\n<li>Birden fazla biyobenzer lansman planlan\u0131yor<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f <strong>Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/strong><\/h2>\n<ol>\n<li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong> &#8211; Haftal\u0131k yat\u0131r\u0131mlarla dolar maliyeti ortalamas\u0131 yap\u0131n<\/li>\n<li><strong>Fiyat uyar\u0131lar\u0131 kurun<\/strong> &#8211; 5 Kas\u0131m kazan\u00e7 tarihi civar\u0131n\u0131 takip edin<\/li>\n<li><strong>Ak\u0131ll\u0131ca \u00e7e\u015fitlendirin<\/strong> &#8211; Portf\u00f6y\u00fcn\u00fcz\u00fcn %15&#8217;inden az\u0131n\u0131 ila\u00e7 sekt\u00f6r\u00fcne ay\u0131r\u0131n<\/li>\n<li><strong>Esprili yakla\u015f\u0131m<\/strong>: &#8220;TEVA ticareti yapmak ila\u00e7 almak gibidir &#8211; bazen tad\u0131 ac\u0131 olabilir ama uzun vadede portf\u00f6y sa\u011fl\u0131\u011f\u0131n\u0131z i\u00e7in iyidir!&#8221;<\/li>\n<\/ol>\n<h2>\u2705 <strong>Teva Pharmaceutical Industries Limited (TEVA) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/strong><\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir ticaret platformu se\u00e7in<\/td>\n<td>NYSE eri\u015fimi ve par\u00e7al\u0131 hisse sunan bir platform olmas\u0131na dikkat edin<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n<\/td>\n<td>Hisse senedi ticareti uyumlulu\u011fu i\u00e7in gereklidir<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Fon yat\u0131r\u0131n<\/td>\n<td>Risk almaya haz\u0131r oldu\u011funuz bir miktarla ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>&#8220;TEVA&#8221; aramas\u0131 yap\u0131n<\/td>\n<td>Do\u011fru sonu\u00e7lar i\u00e7in sembol\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Sipari\u015f t\u00fcr\u00fcn\u00fc se\u00e7in<\/td>\n<td>Limit emirleri volatilite s\u0131ras\u0131nda fazla \u00f6deme yapman\u0131z\u0131 engeller<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>\u00dccretleri g\u00f6zden ge\u00e7irin<\/td>\n<td>Komisyonsuz platformlar getiriyi maksimize eder<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Al\u0131m\u0131 ger\u00e7ekle\u015ftirin<\/td>\n<td>Sipari\u015f detaylar\u0131n\u0131 onaylay\u0131n ve tamamlay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td>Takip kurun<\/td>\n<td>Fiyat uyar\u0131lar\u0131 performans\u0131 izlemenize yard\u0131mc\u0131 olur<\/td>\n<\/tr>\n<tr>\n<td>9<\/td>\n<td>DRIP&#8217;i d\u00fc\u015f\u00fcn\u00fcn<\/td>\n<td>Otomatik yeniden yat\u0131r\u0131m kazan\u00e7lar\u0131 katlar<\/td>\n<\/tr>\n<tr>\n<td>10<\/td>\n<td>D\u00fczenli olarak g\u00f6zden ge\u00e7irin<\/td>\n<td>\u00c7eyreklik kazan\u00e7lar \u00f6nemli karar noktalar\u0131d\u0131r<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 <strong>Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Pocket Option&#8217;un \u00d6ne \u00c7\u0131kma Nedenleri<\/strong><\/h2>\n<p>Pocket Option, yeni ba\u015flayanlar i\u00e7in tasarlanm\u0131\u015f \u00f6zelliklerle borsa giri\u015fini kolayla\u015ft\u0131r\u0131r:<\/p>\n<ul>\n<li><strong>Sadece 5 $ minimum depozito<\/strong> &#8211; Stratejileri d\u00fc\u015f\u00fck riskle test edin<\/li>\n<li><strong>1 dakikal\u0131k KYC s\u00fcreci<\/strong> &#8211; Tek belge do\u011frulamas\u0131 ile hemen i\u015flem yapmaya ba\u015flay\u0131n<\/li>\n<li><strong>100&#8217;den fazla para \u00e7ekme y\u00f6ntemi<\/strong> &#8211; Karlar\u0131n\u0131za esnek eri\u015fim<\/li>\n<li><strong>Par\u00e7al\u0131 hisse imkan\u0131<\/strong> &#8211; Pahal\u0131 hisselerin par\u00e7alar\u0131n\u0131 sat\u0131n al\u0131n<\/li>\n<li><strong>Ger\u00e7ek zamanl\u0131 piyasa verisi<\/strong> &#8211; G\u00fcncel bilgilerle bilin\u00e7li kararlar verin<\/li>\n<\/ul>\n<p>Platformun kullan\u0131c\u0131 dostu aray\u00fcz\u00fc ve e\u011fitim kaynaklar\u0131, Teva Pharmaceutical Industries Limited (TEVA) hisseleri nas\u0131l al\u0131n\u0131r \u00f6\u011frenirken riski etkin y\u00f6netmek isteyenler i\u00e7in idealdir.<\/p>\n<h2>\ud83c\udf0d <strong>2025&#8217;te Teva: \u0130la\u00e7 Devi D\u00f6n\u00fc\u015f\u00fcm\u00fc<\/strong><\/h2>\n<p>Teva, k\u00fcresel jenerik ila\u00e7 pazar\u0131nda hakimiyet kurarken, daha y\u00fcksek marjl\u0131 yenilik\u00e7i ila\u00e7lara ba\u015far\u0131l\u0131 bir ge\u00e7i\u015f yap\u0131yor. Austedo (hareket bozukluklar\u0131 i\u00e7in), Ajovy (migren \u00f6nleme) ve Uzedy (\u015fizofreni tedavisi) gibi markal\u0131 portf\u00f6y\u00fc, geleneksel jenerik i\u015finin yan\u0131nda \u00f6nemli b\u00fcy\u00fcmeyi sa\u011fl\u0131yor.<\/p>\n<p><strong>2025 \u0130lgin\u00e7 Ger\u00e7ek<\/strong>: Teva&#8217;n\u0131n \u0130srail&#8217;deki genel merkezi, havay\u0131 do\u011fal olarak ar\u0131tan ve enerji maliyetlerini %15 azaltan 10.000&#8217;den fazla bitki i\u00e7eren bir &#8220;ya\u015fayan duvar&#8221;a sahip &#8211; s\u00fcrd\u00fcr\u00fclebilirli\u011fe olan ba\u011fl\u0131l\u0131klar\u0131n\u0131n ila\u00e7lar\u0131n \u00f6tesine ge\u00e7ti\u011fini kan\u0131tl\u0131yor!<\/p>\n"},"faq":[{"question":"Teva hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Bir ticaret platformu se\u00e7in, hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n, fon yat\u0131r\u0131n, \"TEVA\" sembol\u00fc ile arama yap\u0131n, uygun sipari\u015f t\u00fcr\u00fcn\u00fc se\u00e7in ve sat\u0131n alma i\u015flemini ger\u00e7ekle\u015ftirin."},{"question":"Teva'n\u0131n 2025-2030 fiyat tahmini nedir?","answer":"2025 sonunda 19-21 $, 2026'da 22-25 $, 2028'de 28-32 $ ve 2030'da 35-40 $ aral\u0131\u011f\u0131nda fiyatlar beklenmektedir."},{"question":"Teva hisseleri i\u00e7in \u00f6nemli riskler nelerdir?","answer":"D\u00fczenleyici de\u011fi\u015fiklikler, patent davalar\u0131, jenerik rekabet, d\u00f6viz dalgalanmalar\u0131 ve bor\u00e7 y\u00f6netimi \u00f6nemli riskler aras\u0131ndad\u0131r."},{"question":"Yeni ba\u015flayanlar Teva hissesi al\u0131rken nelere dikkat etmeli?","answer":"K\u00fc\u00e7\u00fck ba\u015flay\u0131n, fiyat uyar\u0131lar\u0131 kurun, portf\u00f6y\u00fcn\u00fcz\u00fc \u00e7e\u015fitlendirin ve \u00e7eyreklik kazan\u00e7 raporlar\u0131n\u0131 takip edin."},{"question":"Pocket Option neden yeni yat\u0131r\u0131mc\u0131lar i\u00e7in uygundur?","answer":"D\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 KYC, \u00e7ok say\u0131da para \u00e7ekme y\u00f6ntemi, par\u00e7al\u0131 hisse imkan\u0131 ve ger\u00e7ek zamanl\u0131 piyasa verisi sunar."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Teva hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Bir ticaret platformu se\u00e7in, hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n, fon yat\u0131r\u0131n, \"TEVA\" sembol\u00fc ile arama yap\u0131n, uygun sipari\u015f t\u00fcr\u00fcn\u00fc se\u00e7in ve sat\u0131n alma i\u015flemini ger\u00e7ekle\u015ftirin."},{"question":"Teva'n\u0131n 2025-2030 fiyat tahmini nedir?","answer":"2025 sonunda 19-21 $, 2026'da 22-25 $, 2028'de 28-32 $ ve 2030'da 35-40 $ aral\u0131\u011f\u0131nda fiyatlar beklenmektedir."},{"question":"Teva hisseleri i\u00e7in \u00f6nemli riskler nelerdir?","answer":"D\u00fczenleyici de\u011fi\u015fiklikler, patent davalar\u0131, jenerik rekabet, d\u00f6viz dalgalanmalar\u0131 ve bor\u00e7 y\u00f6netimi \u00f6nemli riskler aras\u0131ndad\u0131r."},{"question":"Yeni ba\u015flayanlar Teva hissesi al\u0131rken nelere dikkat etmeli?","answer":"K\u00fc\u00e7\u00fck ba\u015flay\u0131n, fiyat uyar\u0131lar\u0131 kurun, portf\u00f6y\u00fcn\u00fcz\u00fc \u00e7e\u015fitlendirin ve \u00e7eyreklik kazan\u00e7 raporlar\u0131n\u0131 takip edin."},{"question":"Pocket Option neden yeni yat\u0131r\u0131mc\u0131lar i\u00e7in uygundur?","answer":"D\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 KYC, \u00e7ok say\u0131da para \u00e7ekme y\u00f6ntemi, par\u00e7al\u0131 hisse imkan\u0131 ve ger\u00e7ek zamanl\u0131 piyasa verisi sunar."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Teva Pharmaceutical Industries Limited (TEVA) Hisseleri Nas\u0131l Al\u0131n\u0131r - Teva Pharmaceutical Industries Limited (TEVA) Hisse Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-teva-pharmaceutical-industries-limited\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Teva Pharmaceutical Industries Limited (TEVA) Hisseleri Nas\u0131l Al\u0131n\u0131r - Teva Pharmaceutical Industries Limited (TEVA) Hisse Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-teva-pharmaceutical-industries-limited\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-20T10:36:54+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-teva-pharmaceutical-industries-limited\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-teva-pharmaceutical-industries-limited\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Teva Pharmaceutical Industries Limited (TEVA) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Teva Pharmaceutical Industries Limited (TEVA) Hisse Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-20T10:36:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-teva-pharmaceutical-industries-limited\/\"},\"wordCount\":22,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-teva-pharmaceutical-industries-limited\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-teva-pharmaceutical-industries-limited\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-teva-pharmaceutical-industries-limited\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-teva-pharmaceutical-industries-limited\/\",\"name\":\"Teva Pharmaceutical Industries Limited (TEVA) Hisseleri Nas\u0131l Al\u0131n\u0131r - Teva Pharmaceutical Industries Limited (TEVA) Hisse Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-teva-pharmaceutical-industries-limited\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-teva-pharmaceutical-industries-limited\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp\",\"datePublished\":\"2025-08-20T10:36:54+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-teva-pharmaceutical-industries-limited\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-teva-pharmaceutical-industries-limited\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-teva-pharmaceutical-industries-limited\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp\",\"width\":1408,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-teva-pharmaceutical-industries-limited\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Teva Pharmaceutical Industries Limited (TEVA) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Teva Pharmaceutical Industries Limited (TEVA) Hisse Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Teva Pharmaceutical Industries Limited (TEVA) Hisseleri Nas\u0131l Al\u0131n\u0131r - Teva Pharmaceutical Industries Limited (TEVA) Hisse Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-teva-pharmaceutical-industries-limited\/","og_locale":"tr_TR","og_type":"article","og_title":"Teva Pharmaceutical Industries Limited (TEVA) Hisseleri Nas\u0131l Al\u0131n\u0131r - Teva Pharmaceutical Industries Limited (TEVA) Hisse Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-teva-pharmaceutical-industries-limited\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-20T10:36:54+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-teva-pharmaceutical-industries-limited\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-teva-pharmaceutical-industries-limited\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Teva Pharmaceutical Industries Limited (TEVA) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Teva Pharmaceutical Industries Limited (TEVA) Hisse Yat\u0131r\u0131m\u0131","datePublished":"2025-08-20T10:36:54+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-teva-pharmaceutical-industries-limited\/"},"wordCount":22,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-teva-pharmaceutical-industries-limited\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-teva-pharmaceutical-industries-limited\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-teva-pharmaceutical-industries-limited\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-teva-pharmaceutical-industries-limited\/","name":"Teva Pharmaceutical Industries Limited (TEVA) Hisseleri Nas\u0131l Al\u0131n\u0131r - Teva Pharmaceutical Industries Limited (TEVA) Hisse Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-teva-pharmaceutical-industries-limited\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-teva-pharmaceutical-industries-limited\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp","datePublished":"2025-08-20T10:36:54+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-teva-pharmaceutical-industries-limited\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-teva-pharmaceutical-industries-limited\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-teva-pharmaceutical-industries-limited\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp","width":1408,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-teva-pharmaceutical-industries-limited\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Teva Pharmaceutical Industries Limited (TEVA) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Teva Pharmaceutical Industries Limited (TEVA) Hisse Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":340152,"slug":"how-to-buy-teva-pharmaceutical-industries-limited","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Teva Pharmaceutical Industries Limited (TEVA) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Teva Pharmaceutical Industries Limited (TEVA)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-teva-pharmaceutical-industries-limited\/"},"pt_AA":{"locale":"pt_AA","id":340153,"slug":"how-to-buy-teva-pharmaceutical-industries-limited","post_title":"Como comprar a\u00e7\u00f5es da Teva Pharmaceutical Industries Limited (TEVA) - Investimento em a\u00e7\u00f5es da Teva Pharmaceutical Industries Limited (TEVA)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-teva-pharmaceutical-industries-limited\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/340150","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=340150"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/340150\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334027"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=340150"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=340150"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=340150"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}